(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.23%) $79.17
(-0.64%) $2.17
(-0.23%) $2 316.90
(-0.06%) $27.59
(0.08%) $985.40
(0.08%) $0.930
(0.05%) $10.90
(0.10%) $0.800
(0.33%) $91.75
Quarter results today
(bmo 2024-05-08)
Expected move: +/- 4.57%
Live Chart Being Loaded With Signals
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate...
Stats | |
---|---|
本日の出来高 | 98 276.00 |
平均出来高 | 458 090 |
時価総額 | 22.34B |
EPS | INR0 ( 2024-05-02 ) |
Last Dividend | INR4.00 ( 2023-02-17 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 13.02 |
ATR14 | INR0.248 (0.07%) |
ボリューム 相関
IOL Chemicals and 相関
10 最も正の相関 | |
---|---|
SHIVALIK.NS | 0.882 |
KRSNAA.NS | 0.842 |
NESTLEIND.NS | 0.831 |
GANECOS.NS | 0.83 |
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
IOL Chemicals and 相関 - 通貨/商品
IOL Chemicals and 財務諸表
Annual | 2022 |
収益: | INR22.17B |
総利益: | INR6.70B (30.22 %) |
EPS: | INR23.70 |
FY | 2022 |
収益: | INR22.17B |
総利益: | INR6.70B (30.22 %) |
EPS: | INR23.70 |
FY | 2022 |
収益: | INR21.68B |
総利益: | INR5.72B (26.37 %) |
EPS: | INR28.56 |
FY | 2021 |
収益: | INR19.46B |
総利益: | INR8.22B (42.24 %) |
EPS: | INR76.21 |
Financial Reports:
No articles found.
IOL Chemicals and Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR4.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR3.00 | 2020-03-18 |
Last Dividend | INR4.00 | 2023-02-17 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR17.00 | -- |
Avg. Dividend % Per Year | 0.77% | -- |
Score | 1.86 | -- |
Div. Sustainability Score | 3.29 | |
Div.Growth Potential Score | 3.39 | |
Div. Directional Score | 3.34 | -- |
Year | Amount | Yield |
---|---|---|
2020 | INR7.00 | 4.09% |
2021 | INR2.00 | 0.27% |
2022 | INR4.00 | 0.84% |
2023 | INR4.00 | 1.10% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SMSPHARMA.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.12% | |
MINDTECK.NS | Dividend Junior | 2023-08-04 | Sporadic | 8 | 0.28% | |
HBSL.NS | Dividend Junior | 2023-08-11 | Sporadic | 12 | 0.78% | |
BEPL.NS | Dividend King | 2023-07-25 | Semi-Annually | 20 | 4.91% | |
RADICO.NS | Dividend Junior | 2023-09-14 | Annually | 22 | 0.24% | |
KHAICHEM.NS | No Dividend Player | 2023-07-21 | Annually | 5 | 0.32% | |
EMAMIPAP.NS | Dividend Junior | 2023-09-05 | Annually | 3 | 0.56% | |
AJANTPHARM.NS | Dividend Knight | 2023-08-04 | Annually | 23 | 0.57% | |
SUNTV.NS | Dividend Knight | 2023-08-22 | Quarterly | 19 | 1.94% | |
NAVNETEDUL.NS | Dividend Junior | 2023-08-07 | Annually | 22 | 1.10% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0774 | 1.500 | 8.45 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.111 | 1.500 | 9.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 13.77 | 1.000 | 6.01 | 6.01 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.96 | 2.00 | 3.35 | 6.69 | [0 - 30] |
freeCashFlowPerShareTTM | 19.96 | 2.00 | 0.0197 | 0.0394 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.345 | 1.000 | 7.59 | 7.59 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.109 | 1.000 | 9.82 | 9.82 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.29 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.18 | 1.000 | 8.77 | 0 | [1 - 100] |
returnOnEquityTTM | 0.111 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.96 | 2.00 | 3.35 | 0.0394 | [0 - 30] |
dividendYielPercentageTTM | 1.298 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.96 | 2.00 | 3.35 | 6.69 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.211 | 1.500 | -4.74 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0529 | 1.000 | -1.178 | 0 | [0.1 - 0.5] |
Total Score | 3.39 |
IOL Chemicals and
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。